Product patents

In accordance with 35 U.S.C. § 287(a), the following table used in conjunction with the FDA-approved product labeling may be used to determine U.S. patents associated with the corresponding U.S. marketed product; additional patents may be pending in the U.S. and in other countries. The following list may not be all inclusive, and other products not listed here may be protected by one or more patents in the U.S. and additional countries.
ESPEROCT® [antihemophilic Factor (recombinant), GlycoPEGylated-exei] lyophilized powder for solution, for intravenous use

Patent information

7,199,223
8,133,977
8,143,378
8,247,536
8,536,126
9,150,848

FIASP® (insulin aspart injection), for subcutaneous or intravenous use

Patent information

6,899,699
7,762,994
8,324,157
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
D724,721
D734,450
D758,571
RE46,363

GLUCAGEN® (glucagon) for injection, for subcutaneous, intramuscular or intravenous use

Patent information

no unexpired patents

LEVEMIR® (insulin detemir injection), for subcutaneous use

Patent information

6,899,699
7,762,994
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
RE 46,363
D724,721
D734,450
D758,571

NORDITROPIN® (somatropin) injection, for subcutaneous use

Patent information

6,899,699
7,762,994
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
RE 46,363
D729,930
D765,833

NOVOEIGHT® (antihemophilic factor, recombinant) lyophilized powder for solution, for intravenous use

Patent information

6,100,061
6,475,725
6,936,441
7,094,574
8,080,414
8,084,251
8,084,252
8,329,465
8,399,620
9,982,033

 

NOVOLIN® 70/30 (human insulin isophane suspension and human insulin injection), for subcutaneous use

Patent information

no unexpired patents

NOVOLIN® N (isophane insulin human suspension), for subcutaneous use

Patent information

no unexpired patents

NOVOLIN® R (human insulin injection), for subcutaneous or intravenous use

Patent information

no unexpired patents

NOVOLOG® (insulin aspart injection), for subcutaneous or intravenous use

Patent information

no unexpired patents

NOVOLOG® MIX 70/30 (insulin aspart protamine and insulin aspart injectable suspension), for subcutaneous use

Patent information

no unexpired patents

NOVOSEVEN® RT (coagulation Factor VIIa, recombinant) lyophilized powder for solution, for intravenous use

Patent information

8,299,029
8,658,597
8,729,022

OZEMPIC® (semaglutide) injection, for subcutaneous use

Patent information

6,899,699
7,762,994
8,114,833
8,129,343
8,536,122
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
RE 46,363
D724,721
D758,571
US 10,335,462

PRANDIN® (repaglinide) tablets, for oral use

Patent information

no unexpired patents

REBINYN® (Coagulation Factor IX (Recombinant), GlycoPEGylated) lyophilized powder for solution for intravenous injection

Patent information

7,138,371
7,416,858
7,473,680
8,404,809
8,632,770
8,791,070

RYBELSUS® (semaglutide) tablets, for oral use

Patent information

8,129,343
8,536,122
9,278,123
10,086,047
10,278,923
D906,513

RYZODEG® 70/30 (insulin degludec and insulin aspart injection), for subcutaneous use

Patent information

6,899,699
7,615,532
7,762,994
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
RE 46,363
D724,721
D734,450
D758,571

SAXENDA® (liraglutide) injection, for subcutaneous use

Patent information

6,268,343
6,899,699
7,762,994
8,114,833
8,846,618
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757                                      
9,968,659
10,220,155  
10,357,616
10,376,652
RE 46,363
D724,721
D734,450
D758,571

TRESIBA® (insulin degludec injection), for subcutaneous use

Patent information

6,899,699
7,615,532
7,762,994
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
RE 46,363
D724,721
D734,450
D758,571

TRETTEN® Coagulation Factor XIII A-Subunit (Recombinant), for intravenous use, lyophilized powder for solution for injection

Patent information

10,391,062

VAGIFEM® (estradiol vaginal tablets)

Patent information

7,018,992

VICTOZA® (liraglutide) injection, for subcutaneous use

Patent information

6,268,343
7,762,994
8,114,833
8,846,618
8,579,869
9,265,893
9,968,659
RE 41,956

XULTOPHY® 100/3.6 (insulin degludec and liraglutide injection), for subcutaneous use

Patent information

6,268,343
6,899,699
7,615,532
7,762,994
8,579,869
8,672,898
8,684,969
8,846,618
8,920,383
8,937,042
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
RE 46,363
D724,721
D734,450
D758,571

SOGROYA® (somapacitan-beco) injection, for subcutaneous use

Patent information

8,779,109
9,695,226

AUTOCOVER®

Patent information

6,855,129
7,553,293
8,075,522
8,728,027

FLEXPEN®

Patent information

7,762,994
8,579,869
9,265,893
RE 41,956

FLEXPRO®

Patent information

6,899,699
7,762,994
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155  
10,357,616
10,376,652
RE 46,363
D729,930
D765,833

FLEXPRO® PENMATE®

Patent information

no unexpired patents

FLEXTOUCH®

Patent information

6,899,699
7,762,994
8,579,869
8,672,898
8,684,969
8,920,383
9,108,002
9,132,239
9,457,154
9,486,588
9,616,180
9,687,611
9,775,953
9,861,757
10,220,155
10,357,616
10,376,652
RE 46,363
D724,721
D734,450
D758,571

NOVOFINE® 32G

Patent information

no unexpired patents

NOVOFINE® PLUS 32G

Patent information

no unexpired patents

NOVOPEN® ECHO®

Patent information

6,663,602
7,241,278                                       
10,245,383

NOVOTWIST®

Patent information

7,654,986
7,762,994
8,137,325
8,579,869
D675,316

PENFILL®

Patent information

no unexpired patents

PENFILL® Cartridge

Patent information

7,762,994
8,579,869

PromoMats ID: US20NNG00072 November 2020